Header Logo

Connection

Sheila Weinmann to Prostatic Neoplasms

This is a "connection" page, showing publications Sheila Weinmann has written about Prostatic Neoplasms.
Connection Strength

2.424
  1. Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting. J Urol. 2016 06; 195(6):1748-53.
    View in: PubMed
    Score: 0.429
  2. Association of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8(4):e374-81.
    View in: PubMed
    Score: 0.365
  3. Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate. 2013 Sep; 73(13):1371-7.
    View in: PubMed
    Score: 0.359
  4. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control. 2010 Jan; 21(1):117-25.
    View in: PubMed
    Score: 0.280
  5. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology. 2005 May; 16(3):367-76.
    View in: PubMed
    Score: 0.206
  6. Prostate cancer screening and mortality: a case-control study (United States). Cancer Causes Control. 2004 Mar; 15(2):133-8.
    View in: PubMed
    Score: 0.190
  7. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nat Commun. 2022 05 13; 13(1):2559.
    View in: PubMed
    Score: 0.168
  8. Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery. Eur Urol Oncol. 2019 09; 2(5):589-596.
    View in: PubMed
    Score: 0.133
  9. Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease. J Clin Oncol. 2017 Jun 20; 35(18):1991-1998.
    View in: PubMed
    Score: 0.118
  10. 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
    View in: PubMed
    Score: 0.114
  11. Racial differences in treatment of early-stage prostate cancer. Urology. 2008 Jun; 71(6):1172-6.
    View in: PubMed
    Score: 0.062

© 2025 Kaiser Permanente